Rankings
▼
Calendar
ACLX (Arcellx, Inc.) Stock Financials & Earnings | Market Cap Arena
ACLX
Arcellx, Inc.
Mkt Cap
$7B
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$22M
Net Income (TTM)
-$229M
EPS (TTM)
-$4.06
Free Cash Flow (TTM)
-$213M
Gross Margin
-64.8%
Op. Margin
-1135.6%
Net Margin
-1027.3%
FCF Margin
-953.9%
P/S Ratio (TTM)
300.2x
P/E Ratio (TTM)
—
YoY Rev Growth
-79.4%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$18M
$17M
-$30M
Q2 23
$14M
$14M
-$30M
Q3 23
$15M
$15M
-$45M
Q4 23
$63M
$62M
$15M
Q1 24
$39M
$38M
-$16M
Q2 24
$27M
$26M
-$35M
Q3 24
$26M
$26M
-$34M
Q4 24
$15M
$15M
-$53M
Q1 25
$8M
$8M
-$69M
Q2 25
$8M
$8M
-$59M
Q3 25
$5M
-$30M
-$62M
Q4 25
$2M
$13K
-$64M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
373.5x
—
Q2 23
207.7x
—
Q3 23
141.8x
—
Q4 23
60.6x
—
Q1 24
50.8x
—
Q2 24
46.2x
—
Q3 24
42.9x
—
Q4 24
62.0x
—
Q1 25
87.1x
—
Q2 25
117.4x
—
Q3 25
186.4x
—
Q4 25
300.2x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
$182M
$181M
Q2 23
-$23M
-$30M
Q3 23
-$10M
-$18M
Q4 23
$58M
$53M
Q1 24
-$32M
-$38M
Q2 24
-$36M
-$39M
Q3 24
$31M
$28M
Q4 24
-$46M
-$48M
Q1 25
-$63M
-$64M
Q2 25
-$40M
-$40M
Q3 25
-$49M
-$50M
Q4 25
-$58M
-$59M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$980K
Q2 23
$7M
Q3 23
$8M
Q4 23
$5M
Q1 24
$6M
Q2 24
$3M
Q3 24
$2M
Q4 24
$1M
Q1 25
$780K
Q2 25
$487K
Q3 25
$296K
Q4 25
$764K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
—
+85.4%
Q2 23
—
+40.2%
Q3 23
—
-36.3%
Q4 23
—
+20.4%
Q1 24
+119.2%
+13.8%
Q2 24
+91.5%
+42.2%
Q3 24
+74.0%
-0.3%
Q4 24
-75.8%
+42.1%
Q1 25
-79.3%
+39.9%
Q2 25
-72.4%
+6.3%
Q3 25
-81.0%
+11.9%
Q4 25
-89.2%
-4.5%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$10M
56.7%
Q2 23
$0
0.0%
Q3 23
$11M
71.0%
Q4 23
$11M
16.8%
Q1 24
$15M
37.8%
Q2 24
$15M
55.3%
Q3 24
$15M
58.9%
Q4 24
$16M
103.3%
Q1 25
$24M
293.0%
Q2 25
$18M
239.3%
Q3 25
$18M
362.2%
Q4 25
$18M
1092.6%
marketcaparena.com
OpEx Breakdown
R&D
G&A
SG&A
Quarter
R&D
G&A
SG&A
Q1 23
$33M
—
$15M
Q2 23
$28M
—
$15M
Q3 23
$44M
$16M
—
Q4 23
$29M
$19M
—
Q1 24
$32M
$23M
—
Q2 24
$41M
$21M
—
Q3 24
$39M
$20M
—
Q4 24
$45M
$24M
—
Q1 25
$51M
$26M
—
Q2 25
$38M
$29M
—
Q3 25
$35M
$32M
—
Q4 25
$34M
—
$30M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$275M
$259M
$534M
Q2 23
$304M
$203M
$506M
Q3 23
$126M
$314M
$440M
Q4 23
$395M
$307M
$702M
Q1 24
$155M
$419M
$574M
Q2 24
$100M
$417M
$517M
Q3 24
$162M
$412M
$574M
Q4 24
$106M
$482M
$587M
Q1 25
$81M
$462M
$543M
Q2 25
$62M
$391M
$453M
Q3 25
$79M
$382M
$461M
Q4 25
$80M
$370M
$450M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
47M
+6.0%
Q2 23
48M
+2.9%
Q3 23
48M
+0.7%
Q4 23
52M
+7.9%
Q1 24
53M
+0.9%
Q2 24
54M
+1.4%
Q3 24
54M
+0.6%
Q4 24
54M
-0.2%
Q1 25
55M
+2.9%
Q2 25
56M
+1.7%
Q3 25
57M
+0.7%
Q4 25
56M
-0.5%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 18
—
—
FY 19
—
—
FY 20
—
—
FY 21
$0
78
FY 22
$0
98
FY 23
$849K
130
FY 24
$662K
163
FY 25
$223
100K
marketcaparena.com